This is the mail archive of the ecos-bugs@sources.redhat.com mailing list for the eCos project.


Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]
Other format: [Raw text]

Owning these shares


                                           HOT SHOT STOCK ALERT
                                      EXCITING  ISSUE PGCN  GET IN NOW!!!
                                       ONLINE OFFERING! Monday, June 13th

                                               SYMBOL:  PGCN


OTC Ticker: PGCN
Current Price: $1.01   (UP 0.49 (96.08%)
This stock is at its 52wk high today and the news is not even out yet!

  Pingchuan Summary:
Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN) was
established in March 2001 in Harbin city, P.R.China. It is a modernized
pharmaceutical manufacturer with first-class medical R&D ability, pioneered
medicine products, and well-established marketing network.

Harbin Pingchuan Traditional Chinese Medicine Research Institute was
established in June 1998, with a registered capital of US$120,000. Currently
it has 60 employees, 20 of them are professionals and experts on diabetes.
Functioning as the R&D base of PINGCHUAN, the institute focuses on R & D of
new medicines, particularly those on diabetes.

Since the establishment of 2001, PINGCHUAN has developed a series of
diabetes medicine, including antibiotics, chemical medical capsules and
traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the
successful products of PINGCHUAN for treating diabetes. It was first
developed in 1998 and introduced to the market in 2001. PINGCHUAN also
produces medical intermediates and pharmaceutical preparations, medical
instruments, health care food and other related products.

PINGCHUAN has well-established marketing network and sale branches,
including about 180,000 retail pharmacies/drugstores across China, agency
network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an,
special sales counter at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing through
the company's website. The marketing network of PINGCHUAN covers more than
50% districts of China and exports to US, Japan, Russia, and south-eastern
Asia.

Example:
CWTD in February 2004 at 90 cents before it went to $8.50, an increase of
800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of $13.30
over 400 PERCENT !!!  But We expect much more from PGCN, Sit back and watch.


Disc:
Information
within this email contains "forwardlooking statements" within the meaning of
Section 27Aof the Securities Act of 1933 and Section 21B of
theSecurities Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, expectations, beliefs,
plans,projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking
statements."Forwardlooking statements are based on
expectations,estimates and projections at the time the statements are
made that involve a number of risks and uncertainties which could cause
actual results or events to differ materially from those
presently anticipated. Forward looking statements in this action may be
identified through the use of words such as"projects", "foresee", "expects",
"will,""anticipates," "estimates," "believes," "understands"or that by
statements indicating certain actions"may," "could," or "might" occur.
 Risk factors include general economic and business conditions, the ability
to
acquire and develop specific projects, the ability  to fund operations and
changes in consumer and business consumption habits and other factors
overwhich the company has little or no control. The publisher of this
newsletter does not represent that the information contained in this message
states all material facts or does not omit a material fact necessary to
make the statements therein not misleading. All information provided within
this email pertaining to investing, stocks, securities must be understood
as information provided and not investment advice. The publisher of this
newsletter advises all readers and subscribers to seek advice from
a registered professional securities representative before deciding to
trade in stocks featured within this email. None of the material within this
report shall be construed as any kind of investment advice
or solicitation. Many of these companies are on the verge of bankruptcy.
You can lose all your money by investing in this stock. We urge you to read
the company's SEC filings now, before you invest. The publisher of this
newsletter is not a registered investment advisor. Subscribers should not
view information herein as legal, tax, accounting or investment
advice. In compliance with the SecuritiesAct of 1933, Section
17(b),The publisher of this newsletter is contracted to receive free
trading shares from a third party, not an officer,director or
affiliate shareholder for the circulation of this report. Be aware of an
inherent conflict of interest resulting from such compensation due to
the fact that this is a paid advertisement and is not without bias.The
party that paid us has a position in the stock they will sell at anytime
without notice.This could have a negative impact on the price of
the stock, causing you to lose money. All factual information in this
report was gathered from public sources, including but not limited to SEC
filings,Company Websites and Company Press Releases. The publisher of this
newsletter believes this informationto be reliable but can make no
guarantee as to its accuracy or completeness. Use of the material
within this email constitutes your acceptance of these terms.






Index Nav: [Date Index] [Subject Index] [Author Index] [Thread Index]
Message Nav: [Date Prev] [Date Next] [Thread Prev] [Thread Next]